• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喜树碱对人拓扑异构酶I DNA切割的序列依赖性效应

Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage.

作者信息

Kjeldsen E, Mollerup S, Thomsen B, Bonven B J, Bolund L, Westergaard O

机构信息

Department of Molecular Biology and Plant Physiology, University of Aarhus, Denmark.

出版信息

J Mol Biol. 1988 Jul 20;202(2):333-42. doi: 10.1016/0022-2836(88)90462-7.

DOI:10.1016/0022-2836(88)90462-7
PMID:2845097
Abstract

We have studied the effect of the antitumor drug, camptothecin, on the interaction of human topoisomerase I with DNA at the sequence level. At a low molar ratio of enzyme to DNA, cleavage is prominent and unique, located at a previously described hexadecameric recognition sequence, while a number of strong additional cleavage sites appear in the presence of the drug. Camptothecin stimulates cleavage at the recognition sequence less than twofold, whereas cleavage at the additional sites is stimulated up to 200-fold. Camptothecin greatly enhances the stability of the cleavable complexes formed at the additional sites, whereas the complex formed at the hexadecameric sequence is only marginally affected. Cleavage was eliminated at certain sites in the presence of camptothecin. Taken together these observations demonstrate that at least three types of potential eukaryotic topoisomerase I cleavage sites can be distinguished by the use of camptothecin. Comparison of the sequences at the additional cleavage sites in the presence of camptothecin reveals that the most frequently cleaved dinucleotide is TG with no consensus for the flanking nucleotides.

摘要

我们已经在序列水平上研究了抗肿瘤药物喜树碱对人拓扑异构酶I与DNA相互作用的影响。在酶与DNA的低摩尔比下,切割作用显著且独特,位于先前描述的十六聚体识别序列处,而在药物存在的情况下会出现许多额外的强切割位点。喜树碱刺激识别序列处的切割作用不到两倍,而在额外位点处的切割作用则被刺激高达200倍。喜树碱极大地增强了在额外位点形成的可切割复合物的稳定性,而在十六聚体序列处形成的复合物仅受到轻微影响。在喜树碱存在的情况下,某些位点的切割作用被消除。综合这些观察结果表明,通过使用喜树碱可以区分至少三种潜在的真核生物拓扑异构酶I切割位点。对喜树碱存在时额外切割位点处的序列进行比较发现,最常被切割的二核苷酸是TG,其侧翼核苷酸没有一致序列。

相似文献

1
Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage.喜树碱对人拓扑异构酶I DNA切割的序列依赖性效应
J Mol Biol. 1988 Jul 20;202(2):333-42. doi: 10.1016/0022-2836(88)90462-7.
2
Sequence specificity of DNA topoisomerase I in the presence and absence of camptothecin.喜树碱存在与不存在时DNA拓扑异构酶I的序列特异性
EMBO J. 1987 Jun;6(6):1817-23. doi: 10.1002/j.1460-2075.1987.tb02436.x.
3
Characterization of a camptothecin-resistant human DNA topoisomerase I.一种喜树碱抗性人DNA拓扑异构酶I的特性分析
J Biol Chem. 1988 Mar 15;263(8):3912-6.
4
Camptothecin inhibits both the cleavage and religation reactions of eukaryotic DNA topoisomerase I.
J Mol Biol. 1992 Dec 20;228(4):1025-30. doi: 10.1016/0022-2836(92)90310-g.
5
Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.在有和没有喜树碱的情况下拓扑异构酶I与SV40 DNA的相互作用。
Nucleic Acids Res. 1988 Dec 9;16(23):11157-70. doi: 10.1093/nar/16.23.11157.
6
Sequence dependent modulating effect of camptothecin on the DNA-cleaving activity of the calf thymus type I topoisomerase.喜树碱对小牛胸腺I型拓扑异构酶DNA切割活性的序列依赖性调节作用。
Nucleic Acids Res. 1990 Feb 11;18(3):637-45. doi: 10.1093/nar/18.3.637.
7
Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin.在有和没有喜树碱的情况下,小牛胸腺和小麦胚芽中的拓扑异构酶I酶对拓扑异构酶I cDNA切割的诱导作用。
Nucleic Acids Res. 1993 Nov 11;21(22):5157-66. doi: 10.1093/nar/21.22.5157.
8
Characterization of an altered DNA catalysis of a camptothecin-resistant eukaryotic topoisomerase I.喜树碱抗性真核拓扑异构酶I的DNA催化改变的特征分析
Nucleic Acids Res. 1993 Feb 11;21(3):593-600. doi: 10.1093/nar/21.3.593.
9
Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.喜树碱存在或不存在时局部DNA序列对拓扑异构酶I切割的影响。
J Biol Chem. 1991 Oct 25;266(30):20418-23.
10
DNA sequence selectivity of human topoisomerase I-mediated DNA cleavage induced by camptothecin.喜树碱诱导的人拓扑异构酶I介导的DNA切割的DNA序列选择性
Protein Sci. 2009 Jun;18(6):1326-31. doi: 10.1002/pro.138.

引用本文的文献

1
Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study.拓扑异构酶 I 抑制剂诱导的切割位点的序列选择性:分子动力学研究。
Nucleic Acids Res. 2013 Dec;41(22):10010-9. doi: 10.1093/nar/gkt791. Epub 2013 Sep 9.
2
Cancer therapies utilizing the camptothecins: a review of the in vivo literature.利用喜树碱类药物的癌症疗法:体内文献综述。
Mol Pharm. 2010 Apr 5;7(2):307-49. doi: 10.1021/mp900243b.
3
DNA sequence selectivity of human topoisomerase I-mediated DNA cleavage induced by camptothecin.
喜树碱诱导的人拓扑异构酶I介导的DNA切割的DNA序列选择性
Protein Sci. 2009 Jun;18(6):1326-31. doi: 10.1002/pro.138.
4
A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitro.在体外,人拓扑异构酶I切割复合物可被另一个人拓扑异构酶I分子识别。
Nucleic Acids Res. 2001 Aug 1;29(15):3195-203. doi: 10.1093/nar/29.15.3195.
5
In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.喜树碱诱导的人结肠癌细胞中拓扑异构酶I切割位点的体内测序
Nucleic Acids Res. 1997 Oct 15;25(20):4111-6. doi: 10.1093/nar/25.20.4111.
6
Effect of CPT on the calf thymus Topoisomerase I-mediated DNA breakage-reunion reaction: optimal conditions for the formation and reversal of the CPT trapped Topoisomerase I cleavable complex.喜树碱对小牛胸腺拓扑异构酶I介导的DNA断裂-重连反应的影响:喜树碱捕获的拓扑异构酶I可裂解复合物形成与逆转的最佳条件。
Mol Biol Rep. 1993 Feb;17(2):129-34. doi: 10.1007/BF00996220.
7
Characterization of an altered DNA catalysis of a camptothecin-resistant eukaryotic topoisomerase I.喜树碱抗性真核拓扑异构酶I的DNA催化改变的特征分析
Nucleic Acids Res. 1993 Feb 11;21(3):593-600. doi: 10.1093/nar/21.3.593.
8
Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin.在有和没有喜树碱的情况下,小牛胸腺和小麦胚芽中的拓扑异构酶I酶对拓扑异构酶I cDNA切割的诱导作用。
Nucleic Acids Res. 1993 Nov 11;21(22):5157-66. doi: 10.1093/nar/21.22.5157.
9
The predominant form of mammalian DNA topoisomerase I in vivo has a molecular mass of 100 kDa.哺乳动物DNA拓扑异构酶I在体内的主要形式分子量为100千道尔顿。
Mol Biol Rep. 1994 Mar;19(2):99-103. doi: 10.1007/BF00997154.
10
Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of topoisomerases from mammalian cells.与哺乳动物细胞拓扑异构酶相比,卡氏肺孢子虫拓扑异构酶的选择性抑制作用。
Antimicrob Agents Chemother. 1994 Sep;38(9):1890-8. doi: 10.1128/AAC.38.9.1890.